Eric Lefkofsky Journey at Tempus

Eric Lefkosky, an American entrepreneur and co-founder of various organisations such as Groupon, InnerWorkings, Echo Global Logistics, Uptake and Mediaocean. Furthermore, he is the founder of Light Bank, a capital firm venture based in Chicago. Erick Lefkosfsky was born on September 2, 1969, in Detroit, Michigan in the United States of America. He was raised up in Southfield, Michigan by his parents, his father Bill was a structural engineer and the mother Sanday who was a teacher.

Eric Lefkofsky joined the University of Michigan after graduating from the Southfield-Lathrup High School in the year 1987.In the year 1991 at the University of Michigan, he graduated with honours and proceeded to the University of Michigan Law School, where he attained his Juris Doctorate. Later on, Eric Lefkofsky started his career of purchasing and selling carpet at the University of Michigan.

As the founder of the most influential technical firms Chicago’s and the Groupon, he has contributed millions of dollars towards the cancer research which given him a good stepping stone to take a better approach cancer cure race. Erick Lefkosfky has been actively participating and working on the Tempus, which is a health-tech company that makes facilities to use improved and modern technology in the cancer treatment. The Tempus Company has been working hand in hand with the Light bank which is an early investment that developed into the Chicago, established by Erick Lefkofsky as the firm’s chairperson. He is also recognised as the president of a corporate which deals with the Illinois Secretary of State for the Tempus Health Company.

Click this related link

The Tempus firm deals with assisting the healthcare professionals and doctors in establishing the real, correct data information and making personalised treatment decision using their also helps the doctors to understand the patient’s genetic code in the context of therapies and sequencing of the patient’s tumour. Tempus healthcare firm collects and carries out investigations on the genomically analysed information using the statistics and proprietary algorithms to realise the opportunities to assist patients in providing the best and perfect treatment. Currently, is working to treat patients with lung, pancreatic and breast cancer and have the vision to add more other types of cancer with time.

Follow him at his page.